Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of immune microenvironment in the female reproductive maintenance and regulation: novel insights into the crosstalk of immune cells. | Front Immunol | 2023 | 38223507 | PubTator, text mining | PubMed |
| Altered Gene Expression of IL-35 and IL-36α in the Skin of Patients with Atopic Dermatitis. | Int J Mol Sci | 2023 | 38203575 | PubTator, text mining | PubMed |
| The Role of IL-23 Inhibitors in Crohn's Disease. | J Clin Med | 2023 | 38202231 | PubTator, text mining | PubMed |
| m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy. | Front Immunol | 2023 | 38187373 | PubTator, text mining | PubMed |
| Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes. | Aging (Albany NY) | 2023 | 38159261 | PubTator, text mining | PubMed |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. | Int J Mol Sci | 2023 | 38139431 | PubTator, text mining | PubMed |
| The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants. | J Clin Immunol | 2023 | 38133879 | PubTator, text mining | PubMed |
| Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseases. | J Nanobiotechnology | 2023 | 38129853 | PubTator, text mining | PubMed |
| Potential therapeutic effects of milk-derived exosomes on intestinal diseases. | J Nanobiotechnology | 2023 | 38115131 | PubTator, text mining | PubMed |
| A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia. | Front Cardiovasc Med | 2023 | 38099221 | PubTator, text mining | PubMed |
| Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy. | PLoS One | 2023 | 38096229 | PubTator, text mining | PubMed |
| Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells. | Asia Pac Allergy | 2023 | 38094089 | PubTator, text mining | PubMed |
| Unveiling the role of miR-137-3p/miR-296-5p/SERPINA3 signaling in colorectal cancer progression: integrative analysis of gene expression profiles and in vitro studies. | BMC Med Genomics | 2023 | 38087342 | PubTator, text mining | PubMed |
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. | J Exp Clin Cancer Res | 2023 | 38087324 | PubTator, text mining | PubMed |
| An Important Role in Novel Immune Mechanism and Diagnostic Model of Ankylosing Spondylitis: The CeRNA-ADRB2 Network. | J Inflamm Res | 2023 | 38084105 | PubTator, text mining | PubMed |
Molecular mechanism of Achyranthis bidentatae radix and Morindae officinalis radix in osteoporosis therapy: An investigation based on network pharmacology, molecular docking, and molecular dynamics simulations. | Biochem Biophys Rep | 2023 | 38076660 | PubTator, text mining | PubMed |
| In-depth exploration of the shared genetic signature and molecular mechanisms between end-stage renal disease and osteoporosis. | Front Genet | 2023 | 38075679 | PubTator, text mining | PubMed |
| PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway. | Sci Rep | 2023 | 38071381 | PubTator, text mining | PubMed |
| Multilevel omics for the discovery of biomarkers in pediatric sepsis. | Pediatr Investig | 2023 | 38050541 | PubTator, text mining | PubMed |
| Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy. | Front Pharmacol | 2023 | 38044951 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=5